Latest Health News

Tryptamine Therapeutics has initiated the world’s first clinical trial of its IV-infused psilocin drug, TRP-8803, targeting Binge Eating Disorder, alongside a pioneering EEG biomarker collaboration and new funding.

Infinity Mining Limited reported a net cash outflow of A$143,000 for the September quarter, with cash reserves dwindling to A$30,000. The company is pursuing cost-saving measures and an imminent capital raising to secure its short-term future.

Recce Pharmaceuticals has commenced patient dosing in its pivotal Phase 3 trial for diabetic foot infections in Indonesia, supported by promising antibacterial efficacy data and extended funding arrangements.

Cyclone Metals advances its flagship Iron Bear Project despite a minor delay in drilling caused by First Nations election disputes, while strengthening its cash position through significant share sales.

DGR Global Limited’s Q3 2025 report reveals ongoing project development, strategic equity holdings, and complex legal proceedings shaping its resource company creation model.

Adherium Limited reports a strong quarter with a 55% increase in device shipments and groundbreaking clinical results from its iCARE study, alongside securing over $2.6 million in post-quarter funding.

RooLife Group (ASX, RLG) reported a strategic pivot in Q1 FY2026, landing major supply contracts worth $174 million and raising $2 million to fuel its own-brand product expansion.

Alara Resources has reported a significant production uplift at its Al Wash-hi Majaza mine following the commissioning of two new tailings filter presses, alongside securing the Daris 3A5 mining license and initiating drilling at the Al Mansur Prospect.

InteliCare successfully completed its largest aged care pilot at mecwacare’s Trescowthick Centre and secured $2 million in funding, while navigating a key leadership transition.

InteliCare Holdings reported a $834,000 operating cash outflow for Q3 2025 but bolstered its balance sheet with a $1.8 million capital raise, positioning itself to sustain operations over the coming quarters.

Thrive Tribe Technologies reported a $451,000 net operating cash outflow in Q1 FY26 but bolstered its cash reserves to $589,000 through over $1 million in equity placements. The company progressed its Thrive Tribe Home Base initiative and expanded its digital business units while managing a limited cash runway.

Cleo Diagnostics has secured positive FDA feedback and nearly 1,600 biobank samples, accelerating its ovarian cancer blood test development ahead of a planned 2026 U.S. market entry.